Cost –utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain

ConclusionProviding this screening test to HGEOC patients and their relatives is cost-effective and it allows one to identify a target population with high risk of cancer to provide effective prevention strategies.

Source: Clinical and Translational Oncology - January 8, 2019 Category: Cancer & Oncology Source Type: research